# Feasibility of Gadolinium Contrast Reduced Brain MRI: the Potential of Deep Learning

> **NCT06462924** · PHASE1 · WITHDRAWN · sponsor: **DeepMeds**

## Conditions studied

- Artificial Intelligence
- Deep Learning

## Interventions

- **DEVICE:** DeepGad

## Key facts

- **NCT ID:** NCT06462924
- **Lead sponsor:** DeepMeds
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-08-30
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-09-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants enrolled
- **Last updated:** 2025-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06462924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06462924, "Feasibility of Gadolinium Contrast Reduced Brain MRI: the Potential of Deep Learning". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06462924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*